Connor, Clark & Lunn Investment Management Ltd. has filed a Form 13F-HR, disclosing its equity portfolio as of the close of business on September 30, 2026. The filing lists the firm's principal executive office at 800-1090 West Pender Street in Vancouver, British Columbia.
The report, signed by Derrick Crowe, the Chief Compliance Officer, details the firm's holdings across a broad spectrum of publicly traded companies. The portfolio includes major technology and healthcare names, as well as industrial and consumer staples. Notable positions mentioned in the filing include Apple Inc., with a reported holding of 1,365,449,936 shares; Alphabet Inc. Class A, with 600,286,785 shares; and Advanced Micro Devices Inc., with 496,615,145 shares. In the healthcare sector, the filing lists significant positions in 10x Genomics Inc., Abbott Laboratories, and AbbVie Inc.
The filing also lists a variety of other holdings, including A10 Networks Inc., ABBVIE Inc., Adobe Inc., and ADT Inc. The report serves as a public record of the firm's equity investments during the specified period.
